Perkinelmer, Inc.
NYSE:PKI
| Market Cap (Intraday) | 17.97B |
| Current PE | 27.51 |
| Forward PE | 17.81 |
| 2yr Forward PE | 25.75 |
| 10-Day MA | $136.09 |
| 50-Day MA | $138.02 |
| 200-Day MA | $140.11 |
Perkinelmer, Inc. Stock, NYSE:PKI
940 Winter Street, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.663.6900
Number of Employees: 16700
Description
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.